Latest Breaking News On - Gil blum - Page 6 : comparemela.com

Geron (GERN) Q2 2023 Earnings Call Transcript

GERN earnings call for the period ending June 30, 2023.

Kalpit patelKalpit patelb rileyCorinne jenkinsStephen rosenfieldScott samuelsFaye fellerJohn scarlettAaron feingoldJoel beattyAndrew grethleinCorinne jenkins goldman sachsGil blumRobert driscollUwe platzbeckerGil blum needhamTuuli tsogtbaatar stifel financial corp

Sarepta Therapeutics, Inc (NASDAQ:SRPT) Q2 2023 Earnings Call Transcript

Operator: Good afternoon and welcome to the Sarepta Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.

United statesRaymond jamesPeter marksSalveen richterJosh schwartzTim lugoAnupam ramaIan estepanGena wangDanielle brillWilliam blairGil blumDebjit chattopadhyayDoug ingramJohn boyleColin bristow

Geron Corporation (NASDAQ:GERN) Q2 2023 Earnings Call Transcript

Operator: Good afternoon, everyone. Welcome to the Geron Corporation Second Quarter 2023 Earnings Conference Call.

Uwe platzbeckerRobert driscollAaron feingoldFaye fellerJohn scarlettKalpit patelCorinne jenkinsScott samuelsStephen rosenfieldJoel beattySam ravinaGil blumAndrew grethleinGeron corporation second quarterGeron corporationCorporate communications

Sarepta Therapeutics (SRPT) Q2 2023 Earnings Call Transcript

SRPT earnings call for the period ending June 30, 2023.

United statesRaymond jamesLouise rodino klapacWilliam blairBrian skorneyJoseph schwartzAnupam rama jpmorganAmerica merrill lynchSalveen richterGena wang barclaysLos angelesDebjit chattopadhyayDebjit chattopadhyay guggenheimAnupam ramaTim lugoGil blum

StockWatch: After $50M from Nvidia, Investors Bullish on Recursion

StockWatch: After $50M from Nvidia, Investors Bullish on Recursion
genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.

Nvidia bionemoNvidia gpusGil blumMani forooharScott schoenhausCatherined cathie woodEquity research analystRecursion pharmaceuticalsNeedham coSilicon valley basedManaging directorKeybanc capital marketsLeerink partnersRecursion classChief investment officerPortfolio manager catherine